Back to top

If you wish to go to ZacksFunds.com, click OK. If you do not, click Cancel.

Biotechnology Ultra Sector Pro F: (MF: BIPSX)

(MF) As of Aug 27, 2014 06:05 PM ET

 Add to portfolio

$54.36 USD

+0.04 (0.07%)

Zacks MF Rank : 3 - Hold [?]     3    

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

General Information as of Jul 31, 2014

% Yield 0.00
% SEC Yield NA
% YTD Return (as of Jul 31, 2014) 14.16
Objective Health Care - Equity
Peer HL LG

Zacks Premium Research for BIPSX

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Zacks MF Rank [?] Hold 3
MF Research Report

( = Change in last 30 days)

Zacks Mutual Fund #1 Ranked Funds

View the Zacks Mutual Fund Rank Guide

Portfolio Statistics

%Unrealized Gain YTD 18.31
Net Assets (Mil $) 7/31/2014 25.30
%Turnover 7/31/2014 14.00

Allocation

% of Portfolio
Large Growth 65.42
Large Value 0.00
Small Growth 0.00
Small Value 0.00
Foreign Stock 0.00
Emerging Market 0.00
Precious Metal 0.00
Intermediate Bond 0.00
Foreign Bond 0.00
High Yield Bond 0.00

Sector / Country Weightings

As of 7/31/2014 % of Portfolio
Other 42.87
Health 30.28
Services 16.24
Industrial Cyclical 7.90
Technology 2.71

Portfolio Holdings

Top Equity Holdings
(As of 4/30/2014)
% of Portfolio Value (Mil$)
GILEAD SCIENCES INC 14.06 60.00
AMGEN INC 9.82 41.89
ABBVIE INC 9.64 41.13
BIOGEN IDEC INC 7.90 33.71
CELGENE CORP 6.94 29.61
ALEXION PHARMACEUTICALS I 3.66 15.62
REGENERON PHARMACEUTICALS 2.69 11.49
ILLUMINA INC 2.04 8.70
VERTEX PHARMACEUTICALS IN 1.86 7.95

Stock Holding % of Net Assets

As Of 4/30/2014
Total Issues 27
Avg. P/E 42.45
Avg. P/Book 6.07
Avg. EPS Growth 15.83
Avg. Market Value (Mil $) 68,453

Risk

3 Year 5 Year 10 Year
Beta 1.32 1.27 1.03
Alpha 31.56 12.57 13.10
R Squared 0.36 0.39 0.29
Std. Dev. 26.80 26.83 28.09
Sharpe 2.32 1.42 2.00